Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Participants were randomized to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks
No external party paid for, sponsored, or had editorial input into this article
To meet demand, drug maker Lilly has taken steps to ramp up production of tirzepatide, committing billions to a new manufacturing plant dedicated to producing more of the drug, the company announced in May
Products purchased through online marketplaces or unknown suppliers may differ in: * Benzyl alcohol concentration * pH balance * Sterility * Manufacturing quality * Storage and shipping conditions These differences can negatively affect the reconstitution process and may contribute to issues such as cloudiness, precipitation, incomplete dissolution, or other inconsistencies
US$ 21.17
US$ 21.54
US$ 23.88
US$ 26.65
